Neonatal cerebral hypoxia-ischemia: The effect of adenosine receptor antagonists

Neuropharmacology

Volumn 36, Issue 9, 1997, Pages 1327-1338

  Bona, E ^a   Aden U ^b   Gilland, E ^a   Fredholm, B B ^b   Hagberg, H ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Brain; DPCPX; Hypoxia; Ischemia; Neonatal; SCH 58261; Theophylline

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN HYPOXIA; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0343852967     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00139-1     Document Type: Review

References (89)

1. Abe H. and Nowak T. S. (1996) Gene expression and induced tolerance following brief insults. Acta Neurobiologia Experimentia 56: 3-8.
2. Abe K. and Kogure K. (1993) Selective gene expression after brain ischaemia. Progress in Brain Research 96: 221-236.
3. Andiné P., Thordstein M., Kjellmer I., Nordborg C., Thiringer K., Wennberg E. and Hagberg H. (1990) Evaluation of brain damage in a rat model of neonatal hypoxic-ischemia. Journal of Neuroscience Methods 35: 253-260.
4. Andiné P., Sandberg M., Bågenholm R., Lehmann A. and Hagberg H. (1991) Intra-and extracellular changes of amino acids in the cerebral cortex of the neonatal rat during hypoxia-ischemia. Developmental Brain Research 64: 115-120.
5. Ådén U., Lindström K., Bona E., Hagberg H. and Fredholm B. B. (1994) Changes in adenosine receptors in the neonatal rat brain following hypoxic ischemia. Molecular Brain Research 23: 354-358.
6. Barnes P. J. and Pauwels R. A. (1994) Theophylline in the management of asthma: time for reappraisal? European Respiratory Journal 7: 579-591.
7. Benveniste H., Drejer J., Schousboe A. and Diemer N. H. (1984) Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. Journal of Neurochemistry 43: 1369-1374.
8. 2A adenosine receptors on sleep-waking patterns in rats. Drug Development Research 37: 65-72.
9. Blomgren K., McRae A., Bona E., Saido T. C., Karlsson J.-O. and Hagberg H. (1995) Degradation of fodrin and MAP 2 after neonatal cerebral hypoxic-ischemia. Brain Research 684: 136-142.
10. Bona E., Ådén U., Fredholm B. B. and Hagberg H. (1995a) The effect of long term cafeine treatment on hypoxic-ischemic brain damage in the neonate. Pediatric Research 38: 312-318.
11. Bona E., Ådén U., Fredholm B. B. and Hagberg H. (1995b) Reduction of neonatal hypoxic-ischemic brain damage after acute adenosine antagonist treatment. Pediatric Research 37: 376A.
12. Busto R., Globus M. Y. T., Martinez E., Valdes I. and Ginsberg M. D. (1991) Comparative effects of transient global ischemia on extracellular levels of adenosine in vulnerable and non-vulnerable brain regions in the rat. Journal of Cerebral Blood Flow and Metabolism 11: S210.
13. Caciagli F., Di Iorio P., Ciccarelli R., Ballerini P., Giuliani P., Shinozaki H. and Nicoletti F. (1995) Class II of metabotropic glutamate receptors modulate the evoked release of adenosine and glutamate from rat hippocampal slice. Pharmacology Research 31S: 167.
14. Clark W. M., Madden K. P., Rothlein R. and Zivin J. (1991) Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke 22: 877-883.
15. Curran T., Gordon M. B., Rubino K. L. and Sambucetti L. C. (1987) Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2: 79-84.
16. Dragunow M. and Preston K. (1995) The role of inducible transcription factors in apoptotic nerve cell death. Brain Research 21: 1-28.
17. Dragunow M., Beilharz E., Sirimanne E., Lawlor P., Williams C., Bravo R. and Gluckman P. (1994) Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat. Molecular Brain Research 25: 19-33.
18. 1 receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience 22: 813-826.
19. Fastbom J. and Fredholm B. B. (1990) Effects of long-term theophylline treatment on adenosine A1 -receptors in rat brain: autoradiographic evidence for increased receptor number and altered coupling to G-proteins. Brain Research 507: 195-199.
20. Fernandez M., Svenningsson P. and Fredholm B. B. (1996) Adaptive changes in adenosine receptors following long-term treatment with the adenosine receptor agonist R-phenylisopropyl adenosine. Life Science 58: 769-776.
21. 3 receptor activation in rats. European Journal of Pharmacology 298: 293-297.
22. Fredholm B. B. (1982) Adenosine actions and receptors after 1 week treatment with caffeine. Acta Physiologica Scandinavia 115: 283-286.
23. Fredholm B. B. (1995) Adenosine, adenosine receptors and the actions of caffeine. Pharmacology and Toxicology 76: 93-101.
24. Fredholm B. B. (1997) Adenosine and neuroprotection. In: Neuroprotective Agents and Cerebral Ischemia (Green A. R. and Cross A. J., Eds), pp. 259-280. Academic Press, San Diego.
25. Fredholm B. B., Abbracchio M. P., Burnstock G., Daly J. W., Harden T. K., Jacobson K. A., Leff P. and Williams M. (1994) Nomenclature and classification of purinoceptors. Pharmacological Reviews 46: 143-156.
26. 2 receptor antagonist, reduces cerebral ischemic injury in the mongolian gerbil. Life Science 55: 61-65.
27. 1 receptor number. Brain Research 612: 271-277.
28. Gidday J. M., Fitzgibbons J. C., Shah A. R., Kraujalis M. J. and Park T. S. (1995) Reduction in cerebral ischemic injury in the newborn rat by potentiation of endogenous adenosine. Pediatric Research 38: 1-6.
29. Gilland E. and Hagberg H. (1996) NMDA-receptor dependent increase of cerebral glucose utilization after hypoxia-ischemia in the neonatal rat. Journal of Cerebral Blood Flow and Metabolism 16: 1005-1013.
30. Gilland E., Puka-Sundvall M., Andiné P., Bona E. and Hagberg H. (1994) Hypoxic-ischemic injury in the neonatal rat brain: effects of pre-and post-treatment with the glutamate release inhibitor BW1003C87. Developmental Brain Research 83: 79-84.
31. Gordon K. E., Simpson J., Statman D. and Silverstein F. S. (1991) Effects of perinatal stroke on striatal amino acid efflux in rats studied with in vivo microdialysis. Stroke 22: 928-932.
32. Hagberg H., Lehmann A., Sandberg M., Nyström B., Jacobson I. and Hamberger A. (1985) Ischemia-induced shift of inhibitory and excitatory amino acids from intra-to extracellular compartments. Journal of Cerebral Blood Flow and Metabolism 5: 413-419.
33. Hagberg H., Andersson P., Kjellmer I., Thiringer K. and Thordstein M. 1987a Extracellular overflow of glutamate, aspartate, GABA and taurine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia. Neuroscience Letters 78: 311-317.
34. Hagberg H., Andersson P., Lacarewicz J., Jacobson I., Butcher S. and Sandberg M. 1987b Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. Journal of Neurochemistry 49: 227-231.
35. Hagberg H., Andiné P., Fredholm B. B. and Rudolphi K. A. (1990) Effect of the adenosine uptake inhibitor propentofylline on extracellular adenosine and glutamate and evaluation of its neuroprotective efficacy after ischemia in neonatal and adult rats. In: Pharmacology of Cerebral Ischemia (Krieglstein J. and Oberpichler H., Eds), pp. 427-437. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart.
36. Hagberg H., Gilland E., Diemer N. H. and Andiné P. (1994) Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Biology of the Neonate 66: 206-213.
37. Hagberg H., Gilland E., Bona E., Hanson L.-Å., Hahn-Zoric M., Blennow M., Holst M., McRae A. and Söder O. (1996) Enhanced expression of interleukin (IL)-1 and IL-6 mRNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatric Research 40: 603-609.
38. Hirai S. I., Ryseck R. P., Mechta F., Bravo R. and Yaniv M. (1989) Characterization of junD: a new member of the jun proto-oncogene family. EMBO Journal 8: 1433-1439.
39. Jacobson K. A., von Lubitz D. K. J. E., Daly J. W. and Fredholm B. B. (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends in Pharmacological Science 17: 108-113.
40. Johansson B., Lindström K. and Fredholm B. B. (1994) Differences in the regional and cellular localization of c-fos mRNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59: 837-849.
41. Johansson B., Georgiev V., Kuosmanen T. and Fredholm B. B. (1996) Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline-and pentylenetetrazol-induced seizures in mice. Relationship to c-fos expression and receptor binding. European Journal of Neuroscience 8: 2447-2458.
42. Kidney J., Dominguez M., Taylor P. M., Rose M., Chung K. F. and Barnes P. J. (1995) Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. American Journal of Respiratory and Critical Care Medicine 151: 1907-1914.
43. Kitagawa K., Matsumoto M., Kamada T. and Yanagihara T. (1996) Ischemic vulnerability and tolerance in the brain. In: Tissue Perfusion and Organ Function: Ischemia/Reperfusion Injury (Kamada T., Shiga T. and McCuskey R. S., Eds), pp. 85-94. Elsevier Science, Amsterdam.
44. Lamph W. W., Wamsley P., Sassone-Corsi P. and Verma I. M. (1988) Induction of proto-oncogene jun/AP-1 by serum and TPA. Nature 334: 629-631.
45. Lee K. S., Tetzlaff W. and Kreutzberg G. W. (1986) Rapid down regulation of hippocampal adenosine receptors following brief anoxia. Brain Research 380: 155-158.
46. Lidington E., Nöhammer C., Dominguez M., Ferry B. and Rose M. L. (1996) Inhibition of the transendothelial migration of human lymphocytes but not monocytes by phosphodiesterase inhibitors. Clinical and Experimental Immunology 104: 66-71.
47. Liu H. M. and Chen H. H. (1994) c-fos protein expression and ischemic changes in neurons vulnerable to ischemia/hypoxia, correlated with basic fibroblast growth factor. Journal of Neuropathology and Experimental Neurology 53: 598-605.
48. 3 receptor stimulation and cerebral ischemia. European Journal of Pharmacology 263: 59-67.
49. 2A receptor agonist and antagonist. European Journal of Pharmacology 287: 295-302.
50. Lowry O. H. and Passonneau J. V. (1972) A Flexible System of Enzymatic Analysis. Academic Press, New York.
51. Lyons D. T., Vasta F. and Vannucci R. C. (1987) Autoradiographic determination of regional cerebral blood flow in the immature rat. Pediatric Research 21: 471-476.
52. McDonald J. W., Roeser N. F., Silverstein F. S. and Johnston M. V. (1989) Quantitative assessment of neuroprotection against NMDA-induced brain injury. Experimental Neurology 106: 289-296.
53. McRae A., Gilland E., Bona E. and Hagberg H. (1995) Microglia activation after neonatal hypoxic-ischemia. Developmental Brain Research 84: 245-252.
54. 3 receptors on macrophages inhibits tumor necrosis factor-alpha. European Journal of Pharmacology 310: 209-216.
55. Milbrandt J. (1987) A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238: 797-799.
56. Milbrandt J. (1988) Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1: 183-188.
57. Miller L. P. and Hsu C. (1992) Therapeutic potential of adenosine receptor activation in ischemic brain injury. Journal of Neurotrauma 9: S563-S577.
58. Moratalla R., Vickers E. A., Robertson H. A., Cochran B. H. and Graybiel A. M. (1993) Coordinate expression of c-fos and jun B is induced in the rat striatum by cocaine. Journal of Neuroscience 13: 423-433.
59. Nakajima T., Daval J. L., Morgan P. F., Post R. M. and Marangos P. J. (1989) Adenosinergic expression of caffeine-induced c-fos mRNA expression in mouse brain. Brain Research 501: 307-314.
60. 2 adenosine receptor agonists CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neuroscience Letters 138: 169-172.
61. Olsen T. S., Astrup J., Christensen J. and Skriver E. B. (1985) Hemodynamic effects of theophylline in ischemic stroke. In: Cerebral Revascularization for Stroke (Spetzler, R. F., Selman W. R., Carter L. P. and Martin N. A., Eds), pp. 148-153. Thieme-Stratton, New York.
62. 2A receptors. Trends in Pharmacological Science 17: 364-372.
63. 1, and muscarinic bindings in rat hippocampus after transient ischemia. Stroke 21: 771-776.
64. Palmer C. (1995) Hypoxic-ischemic encephalopathy. Therapeutic approaches against microvascular injury, and role of neutrophils, PAF, and free radicals. Clinical Perinatology 22: 481-517.
65. Phillis J. W. (1989) Adenosine in the control of the cerebral circulation. Cerebrovascular Brain Metabolism Reviews 1: 26-54.
66. 2A adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Research 705: 79-84.
67. 1 agonists in dopamine-denervated rats. European Journal of Neuroscience 8: 1176-1181.
68. Porter N. M., Radulovacki M. and Green R. D. (1988) Desensitization of adenosine and dopamine receptors in the rat brain after treatment with adenosine analogs. The Journal of Pharmacology and Experimental Therapeutics 244: 218-225.
69. Puka-Sundvall M., Hagberg H. and Andiné P. (1994) Changes in extracellular calcium concentration in the immature rat cerebral cortex during anoxia is not influenced by MK-801. Developmental Brain Research 77: 146-150.
70. Regli F., Yamaguchi T. and Waltz A. G. (1971) Responses of surface arteries and blood flow of ischemic and nonischemic cerebral cortex to aminophylline, ergotamine tartrate and acetazolamide. Stroke 2: 461-470.
71. Rice J. E., Vannucci R. C. and Brierley J. B. (1981) The influence of immaturity on hypoxic-ischemic brain damage in the rat. Annals in Neurology 9: 131-141.
72. Rudolphi K. A., Keil M. and Grome J. J. (1990) Adenosine - a pharmacological concept for the treatment of cerebral ischemia? In: Pharmacology of Cerebral Ischemia (Krieglstein J. and Oberpichler H., Eds), pp. 439-448. Wissenschaftliche Verlagsgesellschaft, Stuttgart.
73. Rudolphi K. A., Schubert P., Parkinson F. E. and Fredholm B. B. 1992a Adenosine and brain ischemia. Cerebrovascular Brain Metabolism Reviews 4: 346-369.
74. Rudolphi K. A., Schubert P., Parkinson F. E. and Fredholm B. B. 1992b Neuroprotective role of adenosine in cerebral ischemia. Trends in Pharmacological Science 13: 439-445.
75. Ryder K., Lau L. F. and Nathans D. (1988) A gene activated by growth factors is related to the oncogene v-jun. Proceedings of the National Academy of Science of the U.S.A. 85: 1487-1491.
76. Sakurada O., Kennedy C., Jehle J., Brown J. D., Carbin G. L. and Sokoloff L. (1978) Measurement of local cerebral blood flow with iodo[14C]antipyrine. American Journal of Physiology 231: H59-H66.
77. 2 receptor-mediated excitatory actions on the nervous system. Progress in Neurobiology 48: 167-189.
78. Seida M., Wagner H. G., Vass K. and Klatzo I. (1988) Effect of aminophylline on postischemic edema and brain damage in cats. Stroke 19: 1275-1282.
79. Sharma H. S., Van Heugten H. A., Goedbloed M. A., Verdouw R. D. and Lamers J. M. (1994) Angiotensin II induced expression of transcription factors precedes increase in transforming growth factor beta 1 mRNA in neonatal cardiac fibroblasts. Biochemical and Biophysical Research Communications 205: 105-112.
80. Simpson R., O'Regan M., Perkins L. and Phillis J. W. (1992) Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonist and antagonists. Journal of Neurochemistry 58: 1683-1690.
81. Skinhoj E. and Paulson O. B. (1970) The mechanism of action of aminophylline upon cerebral vascular disorders. Acta Neurologica Scandinavia 46: 129-140.
82. Snyder S. H. (1985) Adenosine as a neuromodulator. Annual Review of Neuroscience 8: 103-124.
83. Stein D. T. and Vannucci R. C. (1988) Calcium accumulation during the evolution of hypoxic-ischemic brain damage in the immature rat. Journal of Cerebral Blood Flow and Metabolism 8: 834-842.
84. Svenningsson P., Nomikos G. G. and Fredholm B. B. (1995) Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. Journal of Neuroscience 15: 7612-7624.
85. 2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of mRNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience 79: 753-764.
86. Szaflarski J., Burtrum D. and Silverstein F. S. (1995) Cerebral hypoxia-ischemia stimulates cytokine gene expression in the perinatal rats. Stroke 26: 1093-1100.
87. Vannucci R. C. and Duffy T. E. (1974) Influence of birth on carbohydrate and energy metabolism in rat brain. American Journal of Physiology 226: 933-941.
88. Volpe J. J. (1995) Neurology of the Newborn, pp. 1-876. W.B. Saunders, Philadelphia.
89. Yager J. Y., Heitjan D. F., Towfighi J. and Vannucci R. C. (1992) Effect of insulin-induced and fasting hypoglycemia on perinatal hypoxic-ischemic brain damage. Pediatric Research 31: 138-142.